|
Patient number
|
Age
|
Time from EOT to CMR (mos)
|
Cancer site
|
LGE volume (cc)
|
Dmean EQD2 (Gy) to LGE
|
Dmean EQD2 (Gy) to heart
|
Dmax EQD2 (Gy) to LGE
|
Dmax EQD2 (Gy) to heart
|
D95 EQD2 (Gy) to LGE
|
|---|
|
1
|
87
|
28.3
|
lung
|
2.4
|
6.7
|
4.5
|
28.2
|
41.3
|
0.7
|
|
2
|
50
|
7.7
|
lung
|
0.2
|
16.5
|
4.7
|
25.5
|
48.8
|
0.9
|
|
3
|
67
|
22.1
|
lung
|
5.5
|
12.0
|
6.8
|
43.1
|
108
|
1.3
|
|
4
|
67
|
14.2
|
breast
|
1.0
|
12.4
|
1.8
|
16.1
|
40.8
|
8.7
|
|
5
|
65
|
2.2
|
breast
|
6.1
|
1.7
|
2.3
|
3.7
|
51.3
|
0.9
|
|
6
|
60
|
11.9
|
lung
|
2.2
|
0.4
|
4.1
|
0.5
|
66.6
|
0.3
|
|
7
|
71
|
26.5
|
esophagus
|
2.1
|
6.1
|
8.8
|
16.6
|
51.9
|
2.2
|
|
8
|
56
|
2.2
|
lung
|
0.5
|
10.9
|
21.8
|
13.2
|
69.9
|
9.1
|
|
9
|
74
|
6.0
|
lung
|
0.7
|
0.6
|
6.2
|
0.7
|
68.8
|
0.5
|
|
Average (Range)
|
66 (50–87)
|
13.4 (2.2–28.3)
|
–
|
2.3 (0.2–6.1)
|
7.5 (0.4–16.5)
|
6.8 (1.8–21.8)
|
16.4 (0.5–43.1)
|
60.8 (40.8–108.0)
|
2.7 (0.3–9.1)
|
- * Cc cubic centimeters, CMR cardiac magnetic resonance imaging, Dmax maximum dose, Dmean mean dose, D95 minimum dose to 95% of the LGE volume, EOT end of treatment date, EQD2 equivalent dose in 2Gy fractions, Gy Gray, LGE late gadolinium enhancement, mos months
